Bandingkan Harga & Kinerja Medela Potentia Tbk. (MDLA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Medela Potentia Tbk. dan Organon Pharma Indonesia Tbk.: Medela Potentia Tbk. diperdagangkan di Rp208 (kapitalisasi pasar 2,91 T, volume 24 jam 5,49 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Medela Potentia Tbk. jauh lebih besar — sekitar 27,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MDLA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,91 T | 104,4 M |
Volume | 5,49 jt | — |
Lot | 54,88 rb | — |
Perputaran | 1,14 M | — |
Harga Rata-rata | 208,24 | — |
Nilai Transaksi | 1,14 M | — |
Harga Ekuilibrium Indikatif | 208 | — |
Volume Ekuilibrium Indikatif | 50 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Medela Potentia Tbk.
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Selengkapnya di halaman MDLA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
